Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide

BACKGROUND: Arsenic trioxide [ATO, inorganic arsenite (iAs(III)) in solution] plays an important role in the treatment of acute promyelocytic leukemia (APL). However, the long-term adverse effects (AEs) and the retention of arsenic among APL patients are rarely reported. In this study, we focused on...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Yu, Mao, Yuan-Fei, Zhao, Hui-Jin, Chen, Li, Wang, Li-Ning, Zhang, Yun-Xiang, Hu, Jiong, Li, Jun-Min, Li, Xiao-Yang, Zhu, Hong-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866431/
https://www.ncbi.nlm.nih.gov/pubmed/33549147
http://dx.doi.org/10.1186/s40164-021-00205-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866431/
https://www.ncbi.nlm.nih.gov/pubmed/33549147
http://dx.doi.org/10.1186/s40164-021-00205-6

Ejemplares similares